Electromobility-shift assay (EMSA) 
Introduction
our research investigations revolved around attempts to understand the mode of binding of linker histones -lh (h1, h5, h1 o , and cognates) to DnA in chromatin. Knowing the strong affinity of these histones for DNA-binding, it was accepted that they might play a significant role as general transcriptional regulators because of their contribution to chromatin condensation limiting the access of transcription machinery to DnA (20) . the knowledge of the nature of these interactions is of greatest interest in understanding the regulation of many important biological processes as DnA replication and transcription, cell division, cancerogenesis (4) . During the last decade of research efforts of our crew and other laboratories worldwide, despite a huge progress in this field, many questions remain unanswered. For example, the question whether the LH interact primarily with the major-or minor groove of DnA is still controversial. the lack of crystallographic images that would throw light on that problem, challenged us to use some model systems with DnA-binding small drug molecules (known with DnAgroove preferences) in competitive reactions. the fact that the effective anticancer antibiotic actinomycin D (ActD) is a minor-groove binder prompted us to use the compound in competition experiments aimed to determine whether the lh bind to the DnA via minor-or major groove contacts. Studies on the DNA binding behavior of this drug allow a uniquely valuable insight into general mechanisms whereby small molecules can recognize DnA as a target and thus compete with important DnA-binding proteins involved in various biological processes (2) . Actinomycin D molecule (Fig. 1) contains a planar phenoxizanone (phenoxazone) chromophore with two pentapeptide lactopeptons attached (9, 13) . the heterocycle ring can be inserted (intercalated) between the DnA base pairs and oligopeptide rests invade into the minor groove (2, 5, 6) . Sequence specificity of the drug interaction with DnA has been a subject of many research programs. its prominent preference for binding to Gpc steps has been well characterized (5, 13, 14) . the intimate mechanism of ActD binding to DNA was proposed by Fox and Waring announced as "shuffling hypothesis": the drug molecules initially interact with non-sequence-specific sites on DNA and subsequently "shuffle" along the polymer in a one-dimentional migratory fashion so as to locate their preferred sequence-dependent binding sites with a following invading into DnA minor groove (6) . it was shown also that ActD might bind to other two "imperfect" sites -GpG and GpT (12) . Many investigators have established that due to its stable binding to dsDnA actinomycin D blocks transcript elongation and modulates topoisomerase activities in the cell (2). here we present our recent results of devised competitive assays to estimate the relative binding affinities of linker histones h1, h5, and globular domain of histone h5 (GD5) for actinomycin D-treated DnA compared with untreated, using electromobility-shift assay (eMSA) as a main approach.
Materials and Methods
Choice and preparation of DNA-samples A large, 2073 bp DnA-fragment was derived after Bstni digestion of the Escherichia coli plasmid pUc19. the whole digest was run on 0.8 % agarose gel and the fragment of interest extracted using qUAiGen isolation kit (chatsworth, cA, USA). Double-stranded 34 bp DnA fragment with the following sequence:
5'-GttGActGAtcActctGGtctcAtGctAGtcAAc-3' 3'-cAActGActAGtGAGAccAGAGtAcGAtcAGttG-5' bearing a single Gc-site for ActD-binding, was obtained by annealing of equimolar amounts of single stranded complementary strands, custom synthesized on Applied Biosystem 380B synthesizer (USA). the completeness of reassociation was checked on 15 % native PAGe, AA to nn'-methylene-bis-AA ratio of 29:1. DnA concentration was determined by measuring UV absorbance at 260 nm and calculated applying an extinction coefficient of 20.0 ml -1 x cm -1
x mg -1 (11) .
Antibiotic solutions and drug treatment of DNA
Actinomycin D (Sigma, St. louis, Mo, USA) was dissolved in deionized water up to 10 -2 M stock. All working dilutions were prepared immediately before use. the antibiotic concentration was verified also spectrophotometrically at 440 nm applying a molar extinction coefficient of 24 500 for pure ACTD in water (5) . When needed, before interaction with a protein, the DNA was treated with various quantities of actinomycin D to provide final drug concentration in the mix from 10 -7 to 10 -3 M. incubation was performed at 37 o c for 30 min on dark, in dry thermostat.
Protein purification native histone samples of linker histones h1 (from mouse liver nuclei) and h5 (from chicken erythrocytes) were isolated under nondenaturing conditions according to our recently described procedure (3) . the globular domain of histone h5 (GD5) was derived by limited trypsin digestion (7) . the purified sample solutions were liophyllized in small portions and kept frozen up to use. the histone and GD5 concentrations were determined spectrophotometrically at 230 nm using an extinction coefficients of 1.85 (ml per cm per mg) for histones and 4.5 (ml per cm per mg) for GD5. high-mobility group box protein HMGB1 was purified following the procedure of Adachi et al. (1) by preparative chromatography on a Polybuffer exchange column (PBe94, Pharmacia, Sweden). hMGB1 concentration was measured optically at 280 nm using an extinction coefficient of 1.0 (ml per cm per mg). The purity of isolated proteins was checked on PAGe under denaturing conditions (15 % AA, 0.1 % SDS), at AA to n-n'-methylene bis-AA ratio of 29:1, in tris-glycine running buffer -25 mM Tris-HCl, 250 mM glycine, 0.1% SDS, pH 6.7 (11).
Formation of histone H1/DNA complexes and drugcompetition assay the complexes of linker histones h1, h5 and GD5 with each of the DnA-fragments (large or small, ActD-treated or intact) were created by direct mixing with 1µg DnA in 15 µl sample mixture containing 20 mM tris-hcl, ph 7.5, 20 mM nacl, 0.1 mM eDtA, 0.1mM phenylmethylsulfonyl fluoride (PMSF), at protein to DNA ratio of 1.0 w/w (15, 16, 17) . Following incubation for 25 min at room temperature (usually 23 o c), 1.5 µl of a loading mix (0.1 % bromophenolblue, 30 % glycerol) was added and the samples electrophoresed on 1.0% agarose gel for the large DnA-fragment and on 15 % polyacrylamide gel (29:1 AA to bisAA) for the small 34 bp fragment. the gels were cast and run in 40 mM tAe buffer (40 mM tris, 0.1 mM EDTA, pH 7.5) at electric field voltage of 10V/cm gel. in control samples antibiotic was absent both in free DnA and in its complexes with hh1. the complexes of high-mobility group protein (hMGB1) with large 2073 bp DnA fragment (drug-treated or untreated) were formed as described for the histones except of using a protein/DnA ratio of 2.0 (w/w). After the completion of the electrophoresis, the DnA was visualized by silver-or ethidium bromide staining and the gels were photographed.
Results and Discussion
Drug-competition assay of linker histones and actinomycin D for interaction with 2073 bp DNAfragment the interaction of linker histones h1 and h5 with ActDtreated DnA was monitored by means of electromobilityshift-assay (eMSA). this principal approach in studying protein/DnA interactions relies on the retarded mobility of DNA complexed with proteins in electric field compared with unbound (8) . the complex formation of linker histones h1 and h5 with ActD-treated DnA was investigated as a function of antibiotic concentration. to that end, a 2073 bp DnAfragment was incubated with increasing amounts of ActD and the samples were allowed to form complexes with each of the linker histones. the results are presented in Fig. 2 . the control half of each sample did not contain histone but only DnA treated with various amounts of the drug. After visual inspection of the gel the effect of the antibiotic seemed to be obvious: ActD strongly stimulated the formation of lh/DnA complexes. We have reported similar effects in our previous work with initial data on histone h1/ActD competition (18) . however, the design of these experiments was some different: the incubation of all three components in competitive reactions was performed simultaneously. Many recent studies revealed that, upon binding of ActD, DnA became severely distorted (2, 5, 13, 14) . in our recent works we have established that the linker histones possessed the property of binding to irregular DNA structures in a sequence independent manner (7, 16, 17) . Since the bound ACTD modified conformationally the 2073 bp DNA-fragment bearing multiple "perfect" and "imperfect" sites for the drug binding, the drug-enhancing effect on lh/ DNA interactions might be a consequence of the formation of unusual DnA structures attracting the linker histones. , and a long c-terminal domain (100 amino acids). It was proposed that the structure-specific DnA-binding potential of lh was concentrated in the central globular domain of the peptide molecule (10) . During this series of drug-competititon experiments we have investigated also the DnA-binding properties of the hh5 globular domain (GD5), under the same conditions as with the whole histones. interestingly, as could be seen in Fig. 3 , after DnA treatment at antibiotic concentrations more than 10μM, other different types of soluble protein/DnA complexes appeared (marked in the figure). This response of the mobility of complexes GD5/ ActD-treated DnA to the increasing drug concentrations excludes any simplistic interpretations of the results: it might be expected that the GD5/DnA complexes differ also in their three-dimensional conformations which elicit different mobilities in the electric field.
Effect of actinomycin D on the complex formation of highmobility group box protein (HMGB1) with the same 2073 bp DNA-fragment the linker histones and the nonhistone chromatin proteins hMGB1/2 share many features of DnA-binding behavior although they are structurally unrelated (19) . Because of their similar properties for DnA-binding, a drug-competitive assay with hMGB1 was also performed. Samples containing the same 2073 bp DnA-fragment treated with ActD were incubated with mouse liver hMGB1 under the same conditions as with linker histones instead that the protein to DnA ratio was 2.0 (w/w). As presented in Fig. 4 , the inhibitory effect of ActD was apparent: after incubation of the drug-treated DnA with hMGB1 the DnA-fragment did not change its movement in the electric field while in the control it was involved into protein/DnA complexes and extremely retarded.
Demonstration of actinomycin D-effect on histone H1 interaction with model DNA-fragment bearing a "perfect" target for the drug binding the competition reactions with ActD were applied also to the interaction of hh1 with synthetic 34 bp DnA-fragment designed especially to contain a single "perfect" site (GpC) for the drug binding (Fig. 5) . the samples containing DnA and histone h1 were treated with increasing amounts of ACTD under various conditions described in the text to figure. the enhancing effect of ActD on h1/DnA interaction was apparent: in all experimental samples treated with all the spectrum of antibiotic concentrations the hh1/DnA complex formation was faster than in the control. even a part of DnA remained near to the start positions because of the formation of huge networks of hh1/DnA complexes.
Conclusions
our results on competition reactions of linker histones with actinomycin D for binding to DNA show unequivocally the histone preference for interaction with the drug-modified DNAs (2073 bp plasmid-and 34 bp synthetic fragments) compared with untreated ones. Since it was demonstrated that lh bound preferentially to unusual (mainly bent, curved, kinked) DnAstructures (7, 16, 17) , the observed stimulating effect of ActD on lh/DnA interactions in competitive reactions could be partially explained: the resulting modified structures might be attractive for the histone binding. intercalation of ActD and the subsequent invasion into the DNA minor groove causes double helix conformational changes and major-groove widening (2, 5) . that is why the present results could not answer directly the question about the groove preference of lh: the reason of that preference might be the bent, kinked DnA or the changed major groove dimensions of the double helix. DNA of different sequences may differ in the width of the major-and minor grooves, flexibility, and in electrostatic properties and the effect of the drug might be not equal (5) . That is why the influence of the drug on protein/DNA contacts might vary to a certain degree with different DnAs possessing various nucleotide sequences, length, and/or different number of actinomycin D target sites. competitive experiments with another DnA-fragments bearing different number of targets for ActD-binding are in progress in our laboratory.
Understanding the DnA-proteins recognitions in both sequence-selective and sequence-neutral ways, at the level of successful prediction of binding modes and site selectivity will be instrumental for improvements in the prediction and realization of new molecules as potent and selective generegulatory drugs. Since the binding of the linker histones to DnA is one of the central events in cellular regulation, this interaction might be proposed as a drug target.
